Mark R. Segal
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark R. Segal.
Journal of the American Statistical Association | 1989
Daniel A. Bloch; Mark R. Segal
Abstract In medical studies, the computation of a meaningful incidence rate frequently demands adjustment for covariates. One means for achieving such adjustment is standardization. The (directly) standardized rate is calculated by using the appropriate weighted average of rates over strata determined by the covariates. Thus strata formation is crucial in obtaining good results. This article compares three competing methods for stratification using data from a drug study in which the incidence rate of a certain side effect is of interest. The techniques examined are (a) contingency-table cell aggregation, (b) classification trees, and (c) logistic regression. The relative merits of the three methods are discussed.
Clinical Orthopaedics and Related Research | 1989
David J. Schurman; Daniel A. Bloch; Mark R. Segal; Cary M. Tanner
This study investigates risk factors associated with mechanical loosening of cemented total hip arthroplasties. Mechanical failure was evaluated using survivorship analysis on all arthroplasties performed at the authors institution by the Orthopedic Service from March 1971 until September 1983. Failure was defined as the necessity for replacement of one or more components for any reason other than infection. The failure rate was approximately 1.7% per year and, at 12 years, 20% of the hips had failed. Variables evaluated as potential risk factors for arthroplasty revision included weight, gender, age, surgeon, preoperative functional status, prosthetic type, and diagnosis. A Cox proportional hazard analysis indicated that weight (p less than 0.015) and age (p = 0.087) are important determinants of hip failure. The use of regression trees identified subsets of patients at differing risks for failure. Patients who weighed less than 75.22 kg had the best outcome with a 90% survival to 12 years. Patients weighing more than 75.22 kg are at varying risk depending on their age. These data define a subset of special-risk patients not previously described. Patients weighing more than 75.22 kg who were older than 75.4 years had a revision rate of 73% by eight years.
The American Journal of Clinical Nutrition | 1990
Graham A. Colditz; Walter C. Willett; Meir J. Stampfer; Stephanie J. London; Mark R. Segal; Frank E. Speizer
The American review of respiratory disease | 1988
Eric Garshick; M. B. Schenker; Alvaro Muñoz; Mark R. Segal; Thomas J. Smith; Susan R. Woskie; S K Hammond; Frank E. Speizer
The American review of respiratory disease | 2015
Eric Garshick; M. B. Schenker; Alvaro Muñoz; Mark R. Segal; Thomas J. Smith; Susan R. Woskie; S K Hammond; Frank E. Speizer
The American review of respiratory disease | 1992
Scott T. Weiss; Tor D. Tosteson; Mark R. Segal; Ira B. Tager; Susan Redline; Frank E. Speizer
Statistics in Medicine | 1989
Mark R. Segal; Daniel A. Bloch
The American review of respiratory disease | 1990
Donna R. Parker; George T. O'Connor; David Sparrow; Mark R. Segal; Scott T. Weiss
The American review of respiratory disease | 1989
Susan Redline; Ira B. Tager; Mark R. Segal; Diane R. Gold; Frank E. Speizer; Scott T. Weiss
The American review of respiratory disease | 1987
Ira B. Tager; Mark R. Segal; Alvaro Muñoz; Scott T. Weiss; Frank E. Speizer